GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeouLinBioscience Co Ltd (XKRX:038070) » Definitions » Cyclically Adjusted Price-to-FCF

SeouLinBioscience Co (XKRX:038070) Cyclically Adjusted Price-to-FCF : 261.98 (As of Jun. 20, 2024)


View and export this data going back to 2005. Start your Free Trial

What is SeouLinBioscience Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-20), SeouLinBioscience Co's current share price is ₩8530.00. SeouLinBioscience Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩32.56. SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF for today is 261.98.

The historical rank and industry rank for SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XKRX:038070' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 49.96   Med: 115.14   Max: 392.16
Current: 264.11

During the past years, SeouLinBioscience Co's highest Cyclically Adjusted Price-to-FCF was 392.16. The lowest was 49.96. And the median was 115.14.

XKRX:038070's Cyclically Adjusted Price-to-FCF is ranked worse than
92.38% of 105 companies
in the Biotechnology industry
Industry Median: 50.28 vs XKRX:038070: 264.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

SeouLinBioscience Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ₩38.878. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₩32.56 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


SeouLinBioscience Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeouLinBioscience Co Cyclically Adjusted Price-to-FCF Chart

SeouLinBioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.62 72.65 83.19 110.73 315.66

SeouLinBioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 154.06 - 381.30 315.66 299.73

Competitive Comparison of SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF falls into.



SeouLinBioscience Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=8530.00/32.56
=261.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SeouLinBioscience Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, SeouLinBioscience Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=38.878/118.8477*118.8477
=38.878

Current CPI (Mar. 2024) = 118.8477.

SeouLinBioscience Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -24.105 99.353 -28.835
201409 34.163 99.608 40.762
201412 126.816 99.098 152.090
201503 -269.632 99.720 -321.351
201506 272.810 100.050 324.066
201509 59.152 100.110 70.224
201512 -88.006 100.220 -104.364
201603 -76.549 100.560 -90.470
201606 -435.650 100.790 -513.702
201609 -265.175 101.460 -310.619
201612 310.613 101.560 363.486
201703 -974.715 102.850 -1,126.326
201706 173.544 102.610 201.007
201709 -263.404 103.490 -302.493
201712 112.280 102.990 129.568
201803 -163.458 104.100 -186.615
201806 121.665 104.130 138.861
201809 369.384 105.650 415.527
201812 51.904 104.350 59.115
201903 -78.675 104.490 -89.486
201906 203.966 104.880 231.130
201909 382.770 105.200 432.427
201912 290.098 105.120 327.982
202003 -238.223 105.540 -268.261
202006 108.613 104.870 123.090
202009 -13.064 106.200 -14.620
202012 543.078 105.765 610.252
202103 148.366 107.357 164.246
202106 318.881 107.579 352.285
202109 -137.031 108.759 -149.742
202112 512.963 109.676 555.858
202203 -653.927 111.806 -695.113
202206 184.205 114.083 191.899
202209 147.738 114.831 152.905
202212 -543.357 115.200 -560.561
202303 158.982 116.550 162.117
202306 -742.353 117.140 -753.176
202309 269.094 119.111 268.499
202312 335.087 118.848 335.087
202403 38.878 118.848 38.878

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SeouLinBioscience Co  (XKRX:038070) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


SeouLinBioscience Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of SeouLinBioscience Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


SeouLinBioscience Co (XKRX:038070) Business Description

Traded in Other Exchanges
N/A
Address
4F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 463-400
SeouLinBioscience Co Ltd is a South Korean company operating in biotechnology industry. The company focuses on bio research and production, manufacturing, diagnostics, and healthcare.

SeouLinBioscience Co (XKRX:038070) Headlines

No Headlines